Page last updated: 2024-09-04

1,3,5-triaza-7-phosphaadamantane and Lung Neoplasms

1,3,5-triaza-7-phosphaadamantane has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergamo, A; Brescacin, L; Cocchietto, M; Delfino, R; Dyson, PJ; Geldbach, TJ; Laurenczy, G; Sava, G; Scolaro, C1

Other Studies

1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and Lung Neoplasms

ArticleYear
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Journal of medicinal chemistry, 2005, Jun-16, Volume: 48, Issue:12

    Topics: Adamantane; Animals; Antineoplastic Agents; Benzene Derivatives; Buffers; Cell Line, Tumor; DNA; Female; Humans; Hydrolysis; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Sodium Chloride; Solutions; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays

2005